G Rosti

1.7k total citations
10 papers, 131 citations indexed

About

G Rosti is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, G Rosti has authored 10 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in G Rosti's work include Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lymphoma Diagnosis and Treatment (2 papers). G Rosti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lymphoma Diagnosis and Treatment (2 papers). G Rosti collaborates with scholars based in Italy, Australia and United States. G Rosti's co-authors include S Tura, Michele Baccarani, Giuseppe Bandini, Fabio Efficace, Marie‐Cécile Michallet, Timothy P. Hughes, Richard A. Larson, Andreas Hochhaus, François Guilhot and Hagop M. Kantarjian and has published in prestigious journals such as Blood, Haematologica and PubMed.

In The Last Decade

G Rosti

10 papers receiving 128 citations

Peers

G Rosti

HEMAT

GENET

RHEUM

PFM

PHEOH

Steegmann Jl Spain

N. Pollicardo Italy

Jolanta Dengler Germany

Elisabetta Colaci Italy

Lucy Pemberton United Kingdom

Susanne Jung-Munkwitz Germany

Luis Meillón Mexico

Nadine Pletsch Germany

Ulrike Proetel Germany

J-H Dalle France

Steegmann Jl Spain

G Rosti

133 ×1.2

HEMAT

62 ×0.7

GENET

30 ×0.6

RHEUM

9 ×0.3

PFM

41 ×1.7

PHEOH

Citations per year, relative to G Rosti G Rosti (= 1×) peers Steegmann Jl

Countries citing papers authored by G Rosti

Since Specialization

Citations

This map shows the geographic impact of G Rosti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Rosti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Rosti more than expected).

Fields of papers citing papers by G Rosti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Rosti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Rosti. The network helps show where G Rosti may publish in the future.

Co-authorship network of co-authors of G Rosti

This figure shows the co-authorship network connecting the top 25 collaborators of G Rosti. A scholar is included among the top collaborators of G Rosti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Rosti. G Rosti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Hughes, Timothy P., Andreas Hochhaus, Hagop M. Kantarjian, et al.. (2014). Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily. Haematologica. 99(7). 1204–1211. 37 indexed citations

2.

Baccarani, Michele, Fabio Efficace, & G Rosti. (2014). Moving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burden. Haematologica. 99(2). 205–208. 20 indexed citations

3.

Hochhaus, Andreas, Timothy P. Hughes, Giuseppe Saglio, et al.. (2012). Outcome of Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Based On Early Molecular Response and Factors Associated with Early Response: 4-Year Follow-up Data From Enestnd (Evaluating Nilotinib Efficacy and Safety in Clinical Trials Newly Diagnosed Patients). Blood. 120(21). 167–167. 23 indexed citations

4.

Ispizua, A Urbano, Norbert Schmitz, Francesco Frassoni, et al.. (2002). ALLOGENEIC AND AUTOLOGOUS TRANSPLANTATION FOR HAEMATOLOGICAL DISEASES, SOLID TUMORS AND IMMUNE DISORDERS: DEFINITIONS AND CURRENT PRACTICE IN EUROPE. 29(8). 639–646. 11 indexed citations

5.

Bonini, A, et al.. (1995). Methotrexate and delayed engraftment in allogeneic bone marrow transplantation.. PubMed. 16(5). 729–30. 1 indexed citations

6.

Bandini, Giuseppe, Marie‐Cécile Michallet, G Rosti, & S Tura. (1991). Bone marrow transplantation for chronic lymphocytic leukemia.. PubMed. 7(4). 251–3. 24 indexed citations

7.

Cavo, Michèle, S Tura, G Rosti, et al.. (1991). Allogenic BMT for multiple myeloma (MM). The Italian experience.. PubMed. 7 Suppl 2. 31–31. 7 indexed citations

8.

Testoni, Nicoletta, et al.. (1990). 5q- and t(2;11) in a patient with M2 acute non-lymphocytic leukemia. Case report.. PubMed. 74(6). 595–9. 2 indexed citations

9.

Rosti, G, Alfonso Zaccaria, Nicoletta Testoni, et al.. (1989). Cytogenetic monitoring in CML patients treated with BMT.. PubMed. 4 Suppl 4. 95–7. 3 indexed citations

10.

Rosti, G, Alfonso Zaccaria, Nicoletta Testoni, & S Tura. (1984). Chromosome studies in acute promyelocytic leukemia. An analysis of 11 cases.. PubMed. 69(2). 133–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact